Last updated on July 2019

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Brief description of study

A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Subjects with Newly Diagnosed High-Risk Neuroblastoma.

Clinical Study Identifier: NCT02559778

Find a site near you

Start Over

Helen DeVos Children's Hospital

Grand Rapids, MI United States
  Connect »

Arkansas Children's Hospital

Little Rock, AR United States
  Connect »

Children's Medical Center

Dallas, TX United States
  Connect »

Rady Children's Hospital

San Diego, CA United States
  Connect »

Levine Children's Hospital

Charlotte, NC United States
  Connect »

Phoenix Children's Hospital

Phoenix, AZ United States
  Connect »

Augusta University Health

Augusta, GA United States
  Connect »

St. Lukes

Boise, ID United States
  Connect »

University of Louisville

Louisville, KY United States
  Connect »

Randall Children's Hospital

Portland, OR United States
  Connect »